Thus, considering the relevant functions of hCNT1 as a drug transporter and taking into account the considerable deregulation of miRNAs in these cancers, we sought to address the potential regulation of hCNT1 by miRNAs in colorectal and pancreatic cancers. This evidence concerns the gene SLC28A1 and familial pancreatic carcinoma.